BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30610487)

  • 1. Clinical implications of germline mutations in breast cancer genes: RECQL.
    Bowden AR; Tischkowitz M
    Breast Cancer Res Treat; 2019 Apr; 174(3):553-560. PubMed ID: 30610487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FANCM and RECQL genetic variants and breast cancer susceptibility: relevance to South Poland and West Ukraine.
    Nguyen-Dumont T; Myszka A; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
    BMC Med Genet; 2018 Jan; 19(1):12. PubMed ID: 29351780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline RECQL mutations in high risk Chinese breast cancer patients.
    Kwong A; Shin VY; Cheuk IWY; Chen J; Au CH; Ho DN; Chan TL; Ma ESK; Akbari MR; Narod SA
    Breast Cancer Res Treat; 2016 Jun; 157(2):211-215. PubMed ID: 27125668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline RECQL mutations are associated with breast cancer susceptibility.
    Cybulski C; Carrot-Zhang J; Kluźniak W; Rivera B; Kashyap A; Wokołorczyk D; Giroux S; Nadaf J; Hamel N; Zhang S; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Rudnicka H; Lener M; Masojć B; Tonin PN; Rousseau F; Górski B; Dębniak T; Majewski J; Lubiński J; Foulkes WD; Narod SA; Akbari MR
    Nat Genet; 2015 Jun; 47(6):643-6. PubMed ID: 25915596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe.
    Bogdanova N; Pfeifer K; Schürmann P; Antonenkova N; Siggelkow W; Christiansen H; Hillemanns P; Park-Simon TW; Dörk T
    Fam Cancer; 2017 Apr; 16(2):181-186. PubMed ID: 27832498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in RECQL Gene Are Associated with Predisposition to Breast Cancer.
    Sun J; Wang Y; Xia Y; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Lou H; Xie Y
    PLoS Genet; 2015 May; 11(5):e1005228. PubMed ID: 25945795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RECQL: a new breast cancer susceptibility gene.
    Banerjee T; Brosh RM
    Cell Cycle; 2015; 14(22):3540-3. PubMed ID: 26125302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of mutations predisposing to familial breast cancer in Poland.
    Cybulski C; Kluźniak W; Huzarski T; Wokołorczyk D; Kashyap A; Rusak B; Stempa K; Gronwald J; Szymiczek A; Bagherzadeh M; Jakubowska A; Dębniak T; Lener M; Rudnicka H; Szwiec M; Jarkiewicz-Tretyn J; Stawicka M; Domagała P; Narod SA; Lubiński J; Akbari MR;
    Int J Cancer; 2019 Dec; 145(12):3311-3320. PubMed ID: 31173646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variant Identification in BARD1, PRDM9, RCC1, and RECQL in Patients with Ovarian Cancer by Targeted Next-generation Sequencing of DNA Pools.
    Suszynska M; Ratajska M; Galka-Marciniak P; Ryszkowska A; Wydra D; Debniak J; Jasiak A; Wasag B; Cybulski C; Kozlowski P
    Cancer Prev Res (Phila); 2022 Mar; 15(3):151-160. PubMed ID: 34906988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
    Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
    Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare missense mutations in RECQL and POLG associate with inherited predisposition to breast cancer.
    Tervasmäki A; Mantere T; Hartikainen JM; Kauppila S; Lee HM; Koivuluoma S; Grip M; Karihtala P; Jukkola-Vuorinen A; Mannermaa A; Winqvist R; Pylkäs K
    Int J Cancer; 2018 Jun; 142(11):2286-2292. PubMed ID: 29341116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibility.
    Tavera-Tapia A; de la Hoya M; Calvete O; Martin-Gimeno P; Fernández V; Macías JA; Alonso B; Pombo L; de Diego C; Alonso R; Pita G; Barroso A; Urioste M; Caldés T; Newman JA; Benítez J; Osorio A
    Hum Mutat; 2019 May; 40(5):566-577. PubMed ID: 30817846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic testing in Poland and Ukraine: should comprehensive germline testing of
    Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Steen JA; Theys D; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Stembalska A; Pesz K; Kitsera N; Siekierzynska A; Southey MC; Myszka A
    Genet Res (Camb); 2020 Aug; 102():e6. PubMed ID: 32772980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RECQL: a DNA helicase in breast cancer.
    Akbari MR; Cybulski C
    Oncotarget; 2015 Sep; 6(29):26558-9. PubMed ID: 26387136
    [No Abstract]   [Full Text] [Related]  

  • 15. [The limited spectrum of pathogenic BRCA1 and BRCA2 mutations in the French Canadian breast and breast-ovarian cancer families, a founder population of Quebec, Canada].
    Tonin PN
    Bull Cancer; 2006 Sep; 93(9):841-6. PubMed ID: 16980226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American Women.
    Palmer JR; Polley EC; Hu C; John EM; Haiman C; Hart SN; Gaudet M; Pal T; Anton-Culver H; Trentham-Dietz A; Bernstein L; Ambrosone CB; Bandera EV; Bertrand KA; Bethea TN; Gao C; Gnanaolivu RD; Huang H; Lee KY; LeMarchand L; Na J; Sandler DP; Shah PD; Yadav S; Yang W; Weitzel JN; Domchek SM; Goldgar DE; Nathanson KL; Kraft P; Yao S; Couch FJ
    J Natl Cancer Inst; 2020 Dec; 112(12):1213-1221. PubMed ID: 32427313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients.
    Rashid MU; Muhammad N; Khan FA; Shehzad U; Naeemi H; Malkani N; Hamann U
    Hered Cancer Clin Pract; 2020 Dec; 18(1):25. PubMed ID: 33342430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families.
    Shahi RB; De Brakeleer S; Caljon B; Pauwels I; Bonduelle M; Joris S; Fontaine C; Vanhoeij M; Van Dooren S; Teugels E; De Grève J
    BMC Cancer; 2019 Apr; 19(1):313. PubMed ID: 30947698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human RECQ Helicase Pathogenic Variants, Population Variation and "Missing" Diseases.
    Fu W; Ligabue A; Rogers KJ; Akey JM; Monnat RJ
    Hum Mutat; 2017 Feb; 38(2):193-203. PubMed ID: 27859906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations predisposing to breast cancer in 12 candidate genes in breast cancer patients from Poland.
    Cybulski C; Lubiński J; Wokołorczyk D; Kuźniak W; Kashyap A; Sopik V; Huzarski T; Gronwald J; Byrski T; Szwiec M; Jakubowska A; Górski B; Dębniak T; Narod SA; Akbari MR
    Clin Genet; 2015 Oct; 88(4):366-70. PubMed ID: 25330149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.